Clinical Trial Update: Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of cabozantinib in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Hepatocarcinoma | Phase 2 | Status: UNKNOWN